References

A Practical Approach to the Diagnosis and Management of Chlamydia and Gonorrhea

10.1503/cmaj.221849 · 2023 · External reference

Trachoma

10.1016/s0140-6736(25)00551-3 · 2025 · External reference

Chlamydia Trachomatis: From Urogenital Infections to the Pathway of Infertility

10.3390/genes16020205 · 2025 · External reference

Reactivity of a Dual Amplified Chlamydia Immunoassay With Different Serovars of Chlamydia Trachomatis

10.1258/0956462991914465 · 1999 · External reference

2025 European Guideline on the Management of Chlamydia Trachomatis Infections

10.1177/09564624251323678 · 2025 · External reference

Antimicrobial Treatment and Resistance in Sexually Transmitted Bacterial Infections

10.1038/s41579-024-01023-3 · 2024 · External reference

Impact of Azithromycin, Doxycycline and Redox‐Active Small Molecules on Amoxicillin‐Induced Chlamydia Pneumoniae Persistence

10.1016/j.biopha.2023.115451 · 2023 · External reference

Koalas First: Lessons From A Wildlife Chlamydia Vaccine

10.1016/j.tim.2026.02.003 · 2026 · External reference

Progress Towards Effective Vaccines for Chlamydia Trachomatis

2025 · External reference

Structural Optimization of Covalent Inhibitors for Deubiquitinase ChlaDUB1 of Chlamydia Trachomatis as Antibiotic Agents

10.1021/acs.jmedchem.4c02464 · 2025 · External reference

Design, Biological Evaluation, and Computer‐Aided Analysis of Dihydrothiazepines as Selective Antichlamydial Agents

10.1021/acs.jmedchem.2c01894 · 2023 · External reference

Design, Synthesis and Biological Evaluation of P2‐modified Proline Analogues Targeting the HtrA Serine Protease in Chlamydia

10.1016/j.ejmech.2021.114064 · 2022 · External reference

Kaempferol Inhibits Chlamydia Psittaci Proliferation by Blocking Lipid Transport and RB‐EB Differentiation

10.3389/fmicb.2026.1783916 · 2026 · External reference

Lactobacillus Crispatus BC1 Biosurfactant Counteracts the Infectivity of Chlamydia Trachomatis Elementary Bodies

10.3390/microorganisms9050975 · 2021 · External reference

Discovery of Spilanthol Endoperoxide as A Redox Natural Compound Active Against Mammalian Prx3 and Chlamydia Trachomatis Infection

10.3390/antiox9121220 · 2020 · External reference

The Chlamydial Developmental Cycle

10.1016/j.femsre.2005.03.002 · 2005 · External reference

Pathogenicity and Virulence of Chlamydia Trachomatis: Insights Into Host Interactions, Immune Evasion, and Intracellular Survival

10.1080/21505594.2025.2503423 · 2025 · External reference

Chlamydia Trachomatis Invasion: A Duet of Effectors

10.1042/bst20240800 · 2025 · External reference

Natural Products as Sources of New Drugs Over the Nearly Four Decades From 01/1981 to 09/2019

10.1021/acs.jnatprod.9b01285 · 2020 · External reference

Recent Ring Distortion Reactions for Diversifying Complex Natural Products

10.1039/d2np00027j · 2022 · External reference

Natural Products as Glycolytic Inhibitors for Cervical Cancer Treatment: A Comprehensive Review

10.1016/j.biopha.2024.116708 · 2024 · External reference

Natural Products From Traditional Chinese Medicine: Potential Therapeutic Agents in Cancer Therapy‐Induced Cardiotoxicity

10.2147/dddt.s545216 · 2025 · External reference

Potential Chemopreventive Agents Based on the Structure of the Lead Compound 2‐bromo‐1‐hydroxyphenazine, Isolated From Streptomyces Species, Strain CNS284

10.1021/jm1011066 · 2010 · External reference

Structure‐Activity Relationships of A Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic‐Tolerant Bacterial Biofilms and Mycobacterium Tuberculosis

10.1021/acs.jmedchem.5b02004 · 2016 · External reference

Synthesis and Antichlamydial Activity of Novel Phenazines

10.2174/1570180815666180518112952 · 2019 · External reference

Synthesis and Assessment of 3‐Substituted Phenazines as Novel Antichlamydial Agents

10.2174/1573406415666190708145639 · 2020 · External reference

Studies on Phenazines. XXI. Bromination of Phenazine Derivatives

10.1248/cpb.7.581 · 1959 · External reference

Studies on Phenazines. XXX. Bromination of Phenazine Derivatives by N‐Bromosuccinimide

10.1248/cpb.16.1521 · 1968 · External reference

Synthesis and Biological Evaluation of Nitric Oxide‐Releasing Hybrids From Gemcitabine and Phenylsulfonyl Furoxans as Anti‐Tumor Agents

10.1039/c5md00158g · 2015 · External reference

Synthesis and Biological Evaluation of Novel Farnesylthiosalicylic Acid Derivatives for Cancer Treatment

10.1002/ardp.201300325 · 2014 · External reference

The Asymmetric Buchwald‐Hartwig Amination Reaction

10.1002/anie.202216863 · 2023 · External reference

The Buchwald‐Hartwig Amination After 25

10.1002/anie.201904795 · 2019 · External reference

Design and Synthesis of C3‐Substituted β‐Carboline‐Based Histone Deacetylase Inhibitors With Potent Antitumor Activities

10.1002/cmdc.201700133 · 2017 · External reference

Pyocyanin Inhibits Chlamydia Infection by Disabling Infectivity of the Elementary Body and Disrupting Intracellular Growth

10.1128/aac.02260-17 · 2018 · External reference

Synthesis of 1‐substituted Phenazines as Novel Antichlamydial Agents

10.1080/10286020.2021.1982909 · 2022 · External reference

Heparin‐Binding Outer Membrane Protein of Chlamydiae

10.1046/j.1365-2958.2001.02418.x · 2001 · External reference

A FACS‐Based Genome‐Wide CRISPR Screen Reveals a Requirement for COPI in Chlamydia Trachomatis Invasion

10.1016/j.isci.2018.12.011 · 2019 · External reference

CFTR Is Required for Cellular Entry and Internalization of Chlamydia Trachomatis

10.1042/cbi20090227 · 2010 · External reference

The Chlamydia Trachomatis Ctad1 Invasin Exploits the Human Integrin β1 Receptor for Host Cell Entry

10.1111/cmi.12549 · 2016 · External reference

Hydrogen Sulfide and Ferroptosis Inhibition Underlies the Dietary Restriction‐Induced Protection Against Cyclophosphamide Cystitis

10.3389/fphar.2025.1562852 · 2025 · External reference